Verbena (Verbena officinalis)

Verbena officinalis contains flavonoids and iridoid glycosides that demonstrate acetylcholinesterase inhibition and antioxidant activity in laboratory studies. The herb shows preliminary evidence for cognitive support and anti-inflammatory effects through TNF-α modulation.

Origin & History

Verbena officinalis, commonly known as verbena or vervain, is a perennial herbaceous plant native to Europe, Asia, and North America, belonging to the Verbenaceae family. The aerial parts (herba) are used in herbal medicine, typically extracted using ethanol-water mixtures (2.5-7.5% ethanol) to yield extracts rich in phenolic compounds.

Historical & Cultural Context

Verbena officinalis has a long history in European traditional medicine, where the aerial parts have been used as remedies for inflammation, wounds, and digestive issues. Its traditional use aligns with global herbal medicine practices, supported by the presence of key constituents like verbenalin and hastatoside.

Health Benefits

• Cognitive support through acetylcholinesterase (AChE) inhibition (5.10-5.17 mg GALAE/g in vitro) - Preliminary evidence only
• Antioxidant activity via radical scavenging and phosphomolybdenum reduction - In vitro evidence only
• Anti-inflammatory potential through TNF-α modulation via flavonoid interactions - Computational modeling evidence only
• Enzyme inhibition of tyrosinase (91.91-102.33 mg KAE/g) and α-amylase - In vitro evidence only
• Antimicrobial effects demonstrated in laboratory studies - Preliminary evidence only

How It Works

Verbena's flavonoids inhibit acetylcholinesterase enzyme with activity of 5.10-5.17 mg GALAE/g, potentially supporting cholinergic neurotransmission. The herb's compounds also demonstrate antioxidant activity through radical scavenging and phosphomolybdenum reduction pathways. Anti-inflammatory effects occur via TNF-α modulation by flavonoid constituents.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses on Verbena officinalis were identified in the current research. Evidence is limited to in vitro studies showing antioxidant, enzyme-inhibitory, antibacterial, and anti-inflammatory effects in laboratory settings.

Clinical Summary

Current evidence for verbena comes primarily from in vitro laboratory studies examining enzyme inhibition and antioxidant capacity. No large-scale human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing. The acetylcholinesterase inhibition data represents preliminary biochemical activity only. More robust clinical research is needed to validate potential cognitive and anti-inflammatory benefits in human subjects.

Nutritional Profile

Verbena officinalis (common vervain) is a low-calorie herb used primarily in small culinary and medicinal quantities, so macronutrient contribution is negligible in typical use. Bioactive compounds are the primary nutritional interest. Polyphenols: flavonoids including luteolin (reported ~0.1-0.5 mg/g dry weight), apigenin, and quercetin derivatives are the dominant bioactive class; iridoid glycosides including verbenalin (cornin) and hastatoside (~0.1-1.0 mg/g dry weight in aerial parts) are characteristic marker compounds. Phenylpropanoid glycosides including verbascoside (acteoside) contribute significantly to antioxidant capacity (estimated 1-5 mg/g dry weight in leaf extracts). Volatile essential oils (<0.5% by weight) contain citral, limonene, geraniol, and caryophyllene as principal components. Triterpenoids including ursolic acid and oleanolic acid are present in minor quantities. Tannins contribute to astringency and antioxidant potential. Minerals: limited data, but dried aerial parts contain trace calcium, magnesium, and potassium consistent with leafy herbs. Fiber content of dried herb is estimated at 15-25% of dry weight (structural plant material). Vitamins: minor vitamin C and beta-carotene presence inferred from fresh herb composition, with significant loss upon drying. Bioavailability note: iridoid glycosides show moderate oral bioavailability with gut microbiota-dependent metabolism; flavonoid bioavailability is enhanced by co-consumption with lipids due to lipophilic aglycone forms; verbascoside undergoes extensive first-pass metabolism, limiting systemic absorption to phenolic acid metabolites.

Preparation & Dosage

No clinically studied dosage ranges for human use are available. Current research only includes in vitro studies using various extract concentrations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lemon balm, Passionflower, Chamomile, Rosemary, Sage

Safety & Interactions

Verbena is generally considered safe when used as a traditional herbal preparation, though comprehensive safety data is limited. No significant drug interactions have been documented, but caution is advised with cholinesterase inhibitor medications due to potential additive effects. Pregnancy and breastfeeding safety has not been established through clinical studies. Individuals with acetylcholine-sensitive conditions should consult healthcare providers before use.